Sartorius (Group)

https://www.sartorius.com

Twitter: @Sartorius_Group

LinkedIn: https://www.linkedin.com/company/sartorius

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2020, the company earned sales revenue of some 2.34 billion euros. At the end of 2020, nearly 11,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe. *

	Start	1870-01-01 established
	Industry	laboratory equipment and instruments
	Industry 2	precision instruments (excl laboratory)
	Person	Kreuzburg, Joachim (Sartorius 200305– CEO)
	Person 2	Lehmann, Rainer (Sartorius 201703– CFO before SVP Business Processes Unit)

	Region	Göttingen
	Country	Germany
	Street	94–108 Weender Landstr.
	City	37075 Göttingen
	Tel	+49-551-308-0
		Address record changed: 2020-12-02

Basic data	Employees	H: 10,001 to 50,00 (2020-12-31)
	Currency	EUR
	Annual sales	2,340,000,000 (sales revenue (2020) 2020-12-31)

		* Document for ï¿½About Sectionï¿½: Sartorius AG. (7/2/21). "Press Release: Sartorius Strengthens Product Portfolio for Cell and Gene Therapies by Acquiring a Majority Stake in CellGenix". Göttingen.

		Record changed: 2021-07-02